{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:28:15Z","timestamp":1792506495922,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2016YFD0500101"],"award-info":[{"award-number":["2016YFD0500101"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.vaccine.2018.01.086","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T08:59:04Z","timestamp":1517907544000},"page":"1381-1388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["PED subunit vaccine based on COE domain replacement of flagellin domain D3 improved specific humoral and mucosal immunity in mice"],"prefix":"10.1016","volume":"36","author":[{"given":"Qianniu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouyang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.01.086_b0005","doi-asserted-by":"crossref","unstructured":"Shi W, Jia S, Zhao H, Yin J, Wang X, Yu M, et al. Novel approach for isolation and identification of porcine epidemic diarrhea virus (PEDV) strain NJ using porcine intestinal epithelial cells. Viruses. 2017:9.","DOI":"10.3390\/v9010019"},{"key":"10.1016\/j.vaccine.2018.01.086_b0010","first-page":"357","article-title":"An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration","volume":"11","author":"Collin","year":"2015","journal-title":"BMC Veter Res"},{"key":"10.1016\/j.vaccine.2018.01.086_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2015.07.003","article-title":"Rapid quantitation of porcine epidemic diarrhea virus (PEDV) by Virus Counter","volume":"223","author":"Zhang","year":"2015","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.vaccine.2018.01.086_b0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.virol.2017.06.013","article-title":"The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing epitopes","volume":"509","author":"Okda","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.01.086_b0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11262-014-1055-y","article-title":"Bioinformatics insight into the spike glycoprotein gene of field porcine epidemic diarrhea strains during 2011\u20132013 in Guangdong","volume":"49","author":"Hao","year":"2014","journal-title":"China. Virus Genes"},{"issue":"2","key":"10.1016\/j.vaccine.2018.01.086_b0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4142\/jvs.2017.18.2.237","article-title":"Sequence analysis of the spike gene of porcine epidemic diarrhea virus isolated from South China during 2011\u20132015","volume":"18","author":"Zhao","year":"2016","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2018.01.086_b0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.virol.2016.10.011","article-title":"Characterization of a pathogenic full-length cDNA clone of a virulent porcine epidemic diarrhea virus strain AH2012\/12 in China","volume":"500","author":"Fan","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.01.086_b0040","doi-asserted-by":"crossref","unstructured":"Hoang H, Killian ML, Madson DM, Arruda PHE, Sun D, Schwartz KJ, et al. Full-length genome sequence of a plaque-cloned virulent porcine epidemic diarrhea virus isolate (USA\/Iowa\/18984\/2013) from a Midwestern U.S. Swine Herd. Genome Announcements. 2013:1.","DOI":"10.1128\/genomeA.01049-13"},{"key":"10.1016\/j.vaccine.2018.01.086_b0045","doi-asserted-by":"crossref","first-page":"e0170126","DOI":"10.1371\/journal.pone.0170126","article-title":"Novel Porcine Epidemic Diarrhea Virus (PEDV) variants with large deletions in the spike (S) gene coexist with PEDV strains possessing an intact S gene in domestic pigs in Japan: a new disease situation","volume":"12","author":"Diep","year":"2017","journal-title":"Plos One"},{"issue":"3","key":"10.1016\/j.vaccine.2018.01.086_b0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-animal-022114-111038","article-title":"Strategies for design and application of enteric viral vaccines","volume":"3","author":"Chattha","year":"2015","journal-title":"Ann Rev Animal Biosci"},{"key":"10.1016\/j.vaccine.2018.01.086_b0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vetmic.2016.11.029","article-title":"Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses","volume":"206","author":"Gerdts","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0060","doi-asserted-by":"crossref","unstructured":"Li C, Li W, Lucio de Esesarte E, Guo H, van den Elzen P, Aarts E, et al. Cell attachment domains of the PEDV spike protein are key targets of neutralizing antibodies. J Virol. 2017:91(12).","DOI":"10.1128\/JVI.00273-17"},{"key":"10.1016\/j.vaccine.2018.01.086_b0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fimmu.2017.00585","article-title":"A new adjuvant MTOM mediates mycobacterium tuberculosis subunit vaccine to enhance Th1-Type T cell immune responses and IL-2+ T cells","volume":"8","author":"Yu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0070","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2017.05.028","article-title":"A single dose of the novel chimeric subunit vaccine E2-CD154 confers early full protection against classical swine fever virus","volume":"35","author":"Suarez","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.086_b0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/21645515.2016.1229719","article-title":"Recent advancements in combination subunit vaccine development","volume":"13","author":"Tan","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.01.086_b0080","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00705-014-2163-7","article-title":"Immunogenicity and protective efficacy of recombinant S1 domain of the porcine epidemic diarrhea virus spike protein","volume":"159","author":"Oh","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1016-8478(23)15106-5","article-title":"Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea virus","volume":"14","author":"Chang","year":"2002","journal-title":"Molecules Cells"},{"key":"10.1016\/j.vaccine.2018.01.086_b0090","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.vaccine.2005.01.027","article-title":"Expression of the synthetic neutralizing epitope gene of porcine epidemic diarrhea virus in tobacco plants without nicotine","volume":"23","author":"Kang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.086_b0095","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00299-012-1306-0","article-title":"Immunogenicity of a neutralizing epitope from porcine epidemic diarrhea virus: M cell targeting ligand fusion protein expressed in transgenic rice calli","volume":"31","author":"Nguyen-Xuan","year":"2012","journal-title":"Plant Cell Reports"},{"key":"10.1016\/j.vaccine.2018.01.086_b0100","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1139\/w2012-098","volume":"58","author":"Ge","year":"2012","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0105","doi-asserted-by":"crossref","unstructured":"Tussey L, Strout C, Davis M, Johnson C, Lucksinger G, Umlauf S, et al. Phase 1 safety and immunogenicity study of a quadrivalent seasonal flu vaccine comprising recombinant hemagglutinin-flagellin fusion proteins. Open Forum Infect Dis. 2016;3:ofw015.","DOI":"10.1093\/ofid\/ofw015"},{"key":"10.1016\/j.vaccine.2018.01.086_b0110","doi-asserted-by":"crossref","first-page":"e0147432","DOI":"10.1371\/journal.pone.0147432","article-title":"Immunity elicited by an experimental vaccine based on recombinant flagellin-porcine circovirus type 2 cap fusion protein in piglets","volume":"11","author":"Zhu","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.vaccine.2018.01.086_b0115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fimmu.2017.00326","article-title":"Mucosal and systemic immune responses to influenza H7N9 antigen HA1-2 co-delivered intranasally with flagellin or polyethyleneimine in mice and chickens","volume":"8","author":"Song","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jip.2017.02.004","article-title":"Fusion of flagellin 2 with bivalent white spot syndrome virus vaccine increases survival in freshwater shrimp","volume":"144","author":"Cho","year":"2017","journal-title":"J Invertebr Pathol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/cmi.2015.33","article-title":"Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin","volume":"13","author":"Li","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.rvsc.2015.07.004","article-title":"Development and evaluation of a Salmonella typhimurium flagellin based chimeric DNA vaccine against infectious bursal disease of poultry","volume":"102","author":"Deb","year":"2015","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2018.01.086_b0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12896-015-0195-z","article-title":"An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin","volume":"15","author":"Song","year":"2015","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0140","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4049\/jimmunol.181.3.2036","article-title":"Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity","volume":"181","author":"Nempont","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12896-015-0194-0","article-title":"Hybrid flagellin as a T cell independent vaccine scaffold","volume":"15","author":"Bennett","year":"2015","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0150","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/j.vaccine.2014.06.013","article-title":"A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of influenza B globular head vaccines","volume":"32","author":"Song","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.086_b0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2010.01.077","article-title":"Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy","volume":"392","author":"Liu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2018.01.086_b0160","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4161\/hv.23809","article-title":"Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization","volume":"9","author":"Yang","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.01.086_b0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2017.06.001","article-title":"Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge","volume":"509","author":"Deng","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.01.086_b0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2017.03.029","article-title":"A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice","volume":"143","author":"Wang","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.01.086_b0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virusres.2016.07.010","article-title":"Immunogenicity and protective efficacy of recombinant fusion proteins containing spike protein of infectious bronchitis virus and hemagglutinin of H3N2 influenza virus in chickens","volume":"223","author":"Yin","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.01.086_b0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.086_b0185","doi-asserted-by":"crossref","first-page":"112002","DOI":"10.1103\/PhysRevLett.93.112002","article-title":"Observation of a threshold enhancement in the plambda invariant-mass spectrum","volume":"93","author":"Ablikim","year":"2004","journal-title":"Phys Rev Lett"},{"key":"10.1016\/j.vaccine.2018.01.086_b0190","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1016\/j.vaccine.2009.07.060","article-title":"Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin","volume":"27","author":"Song","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.086_b0195","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/cmi.2011.24","article-title":"Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunization","volume":"8","author":"Zhang","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2018.01.086_b0200","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.4049\/jimmunol.172.11.6922","article-title":"Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response","volume":"172","author":"Didierlaurent","year":"2004","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18301592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18301592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:52Z","timestamp":1759400752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18301592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0264410X18301592"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.086","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PED subunit vaccine based on COE domain replacement of flagellin domain D3 improved specific humoral and mucosal immunity in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}